Hamburg To Step Down, Views Science-Based Regulation As Her Legacy

Hamburg says she is pleased that Stephen Ostroff has agreed to serve as acting commissioner when she leaves. "Since joining the Agency in 2013, and most recently serving as FDA's Chief Scientist, Dr. Ostroff has successfully overseen numerous significant initiatives, while helping to ensur...

Full description

Saved in:
Bibliographic Details
Published in:InsideHealthPolicy.com's FDA Week 2015-02, Vol.21 (5), p.1-6
Main Authors: Durkin, Erin, Haseley, Donna
Format: Article
Language:English
Subjects:
Congressional committees
Laboratories
Leadership
Legislators
Medical equipment
Product reviews
Regulatory agencies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hamburg says she is pleased that Stephen Ostroff has agreed to serve as acting commissioner when she leaves. "Since joining the Agency in 2013, and most recently serving as FDA's Chief Scientist, Dr. Ostroff has successfully overseen numerous significant initiatives, while helping to ensure that scientific rigor, excellence and innovation are infused across the Agency," Hamburg writes in her email.\n
ISSN:2165-4166